alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › acetylcholinesterase-inhibition

acetylcholinesterase-inhibition

3 studies tagged acetylcholinesterase-inhibition, dated 2001-02-06 to 2005-02-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits 2005-02-01
  2. Acetylcholinesterase inhibition in Alzheimer's Disease 2004-01-01
  3. Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning 2001-02-06

Studies

3 studies carry this tag.

Date range

2001 to 2005

Top journals

  • Brain research 1
  • Current pharmaceutical design 1
  • Proceedings of the National Academy of Sciences of the United States of America 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Brain research 2005-02-01 Treatments

    Galantamine is a rather weak acetylcholinesterase (AChE) inhibitor, currently approved for the symptomatic treatment of Alzheimer's disease, with possible additional allosteric potentiating effects at the nicotinic ACh receptor (nAChR).

  2. Acetylcholinesterase inhibition in Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Current pharmaceutical design 2004-01-01 Treatments

    Alzheimer's Disease (AD) is the most common cause for dementia in our ageing population, which leads to a slowly progressive, irretrievable ruination of mental function.

  3. Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Proceedings of the National Academy of Sciences of the United States of America 2001-02-06 Treatments

    Classical eyeblink conditioning is a well-characterized model paradigm that engages the septohippocampal cholinergic system.

All topic tags with their study counts